tiprankstipranks
Trending News
More News >
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
US Market

Defence Therapeutics (DTCFF) Financial Statements

Compare
26 Followers

Defence Therapeutics Financial Overview

Defence Therapeutics's market cap is currently $31.02M. The company's EPS TTM is $; its P/E ratio is -11.18; Defence Therapeutics is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in CAD

Defence Therapeutics Earnings and Revenue History

Defence Therapeutics Debt to Assets

Defence Therapeutics Cash Flow

Defence Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.